Table 1.
At inclusion | 3-monthly | At PSA or symptomatic progression | |
---|---|---|---|
Eligibility check | * | ||
Informed consent | * | ||
PET-CT | * | * | |
QOL questionnaire | * | * | * |
Toxicity assessment | * | * | * |
PSA measurement | * | * | * |
History and physical examination | * | * | * |
*reflects the timepoint of a certain assessment.